Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNECTICS PLC Board/Management Information 2018

Jun 1, 2018

7942_rns_2018-06-01_f9f53764-acde-4578-a5c8-a59c3d8311a0.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9147P

Synectics PLC

01 June 2018

## 1 June 2018

Synectics plc

('Synectics' or the 'Company')

Directorate Change

Synectics plc (AIM: SNX), a leader in the design, integration, control and management of advanced surveillance technology and networked security systems, announces that Mike Stilwell, Group Finance Director, has given notice that he will be leaving Synectics at the end of the Company's financial year on 30th November 2018.

In the period until 30th November, Mike will continue working full time in his current role as normal. Synectics is beginning the process of recruiting a Sheffield-based Group Finance Director as Mike's replacement.

David Coghlan, Chairman of Synectics, commented:

"On behalf of the Board, I'd like to thank Mike for the contribution he has made to the Company since he joined in 2012, and we look forward to working with him to ensure a smooth and orderly handover to his successor during the second half of this year. We wish him well in his future endeavours beyond Synectics."

For further information, please contact:

Synectics plc Tel: +44 (0) 1527 850 080
David Coghlan, Chairman www.synecticsplc.com
email: [email protected]
Stockdale Securities Limited Tel: +44 (0) 20 7601 6100
Tom Griffiths / Henry Willcocks

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOAUAVVRWAAVOAR